However, some studies suggested that the downregulation of ACE2 leads to a more severe stage of COVID-19 and diabetes, and hypertensive patients with reduced ACE2 expression had higher mortality rates due to the increased activity of Ang II [48,49]. This evidence concerns the gene ACE2 and COVID-19.